Providing over-the-counter vaginal oestrogen in New Zealand: a cross-sectional study of pharmacists’ views
Tylah Maniapoto 1 , Amber Young
1 * , Alesha Smith 1
1
Abstract
Genitourinary symptoms of menopause (GSM) affect a large proportion of women and can worsen over time if left untreated. In New Zealand, effective treatment with low-dose vaginal oestrogen is available only by prescription, limiting timely access. Internationally, such treatments have been reclassified for supply by pharmacists, but there are no studies examining New Zealand pharmacists’ perspectives on this.
This study aimed to determine pharmacists’ confidence in treating GSM and their perspectives on supplying an over-the-counter (OTC) vaginal oestrogen.
A cross-sectional survey was distributed by the research team to 2762 registered pharmacists. The survey explored confidence in GSM management, opinions on OTC vaginal oestrogen supply, perceptions of patient preferences, and barriers and facilitators to service delivery. Quantitative data were analysed descriptively, and open-ended responses were reviewed using descriptive thematic analysis.
A total of 299 pharmacists responded (response rate 10.8%). While only 46.8% felt confident in recommending currently available OTC products for GSM, 61.2% reported they would be confident supplying low-dose vaginal oestrogen OTC. Pharmacists believed that supplying OTC oestrogen would improve accessibility, reduce the burden on general practice, and support patient-centred care. Key barriers included cost to patients, lack of specific knowledge of GSM, and limited time or resources in the pharmacy setting.
Pharmacists in New Zealand support expanding their role to supply low-dose OTC vaginal oestrogen for GSM, provided that appropriate tools and training are implemented. This service could improve access, address health disparities, and significantly enhance menopause care in New Zealand.
Keywords: community pharmacy services, genitourinary symptoms, hormonal therapy, menopause, oestrogen, pharmacy, postmenopause, urogenital symptoms, vuvlovaginal atrophy, woman’s health, womens health.
References
1 World Health Organization. Menopause. Geneva, Switzerland: WHO; 2022. Available at https://www.who.int/news-room/fact-sheets/detail/menopause
3 Hutchings HA, Taylor N, Remesh A, et al. A study evaluating quality of life and factors affecting it before, during and after menopause. Eur J Obstet Gynecol Reprod Biol 2023; 289: 100-7.
| Crossref | Google Scholar | PubMed |
4 Da Silva AS, Baines G, Araklitis G, et al. Modern management of genitourinary syndrome of menopause. Fac Rev 2021; 10: 25.
| Crossref | Google Scholar | PubMed |
5 Hirschberg AL, Bitzer J, Cano A, et al. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: an EMAS clinical guide. Maturitas 2021; 148: 55-61.
| Crossref | Google Scholar | PubMed |
6 Palacios S, Stevenson JC, Schaudig K, et al. Hormone therapy for first-line management of menopausal symptoms: practical recommendations. Womens Health 2019; 15: 1745506519864009.
| Crossref | Google Scholar | PubMed |
7 New Zealand Formulary (NZF). estriol (vaginal) Dunedin, New Zealand: New Zealand Medicines Formulary Limited Partnership; 2024. p. 139. Available at https://nzformulary.org [updated 1 January 2024].
8 Matui. Pharmaceutical Collection New Zealand; 2023. Available at www.matui.co.nz
9 Lawton BA, Rose SB, Cormack DM, et al. The menopause symptom profile of Maori and non-Maori women in New Zealand. Climacteric 2008; 11(6): 467-74.
| Crossref | Google Scholar | PubMed |
10 Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev [9] 2012; CD007244.
| Crossref | Google Scholar |
11 Kenda M, Glavač NK, Nagy M, et al. Herbal products used in menopause and for gynecological disorders. Molecules 2021; 26(24): 7421.
| Crossref | Google Scholar | PubMed |
12 Kargozar R, Azizi H, Salari R. A review of effective herbal medicines in controlling menopausal symptoms. Electron Physician 2017; 9(11): 5826-33.
| Crossref | Google Scholar | PubMed |
13 Depypere HT, Comhaire FH. Herbal preparations for the menopause: beyond isoflavones and black cohosh. Maturitas 2014; 77(2): 191-4.
| Crossref | Google Scholar | PubMed |
14 Reed SD, Newton KM, LaCroix AZ, et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008; 15(1): 51-8.
| Google Scholar | PubMed |
15 Brar HS, Marathi R. Case of cholestatic drug-induced liver injury (DILI) associated with black cohosh. BMJ Case Rep 2021; 14(5): e240408.
| Crossref | Google Scholar | PubMed |
16 Chow EC, Teo M, Ring JA, et al. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008; 188(7): 420-2.
| Crossref | Google Scholar | PubMed |
17 Alvisi S, Gava G, Orsili I, et al. Vaginal health in menopausal women. Medicina 2019; 55(10): 615.
| Crossref | Google Scholar | PubMed |
18 Scavello I, Maseroli E, Di Stasi V, et al. Sexual health in menopause. Medicina 2019; 55(9): 559.
| Crossref | Google Scholar | PubMed |
19 Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 2016; 19(2): 151-61.
| Crossref | Google Scholar | PubMed |
20 Cunha AR, Machado RM, Palmeira-de-Oliveira A, et al. Characterization of commercially available vaginal lubricants: a safety perspective. Pharmaceutics 2014; 6(3): 530-42.
| Crossref | Google Scholar | PubMed |
21 Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric 2021; 24(1): 19-24.
| Crossref | Google Scholar | PubMed |
22 Medicines and Healthcare Products Regulatory Agency. Summary of responses to consultation - Gina 10 microgram vaginal tablets. London, UK: GOV.UK; 2022. Available at https://www.gov.uk/government/consultations/consultation-on-proposal-to-make-gina-10-microgram-vaginal-tablets-estradiol-available-from-pharmacies/outcome/summary-of-responses-to-consultation-gina-10-microgram-vaginal-tablets#:~:text=In%20response%20to%20the%20consultation,in%20support%20of%20the%20proposal
23 electronic medicines compendium. Gina 10 micrograms vaginal tablets. United Kingdom: Datapharm Ltd; 2024. Available at https://www.medicines.org.uk/emc/product/13930/rmms#about-medicine
24 Medsafe. Medicines, Product Information: Data Sheets and Consumer Medicine Information; 2017. Available at http://www.medsafe.govt.nz/Medicines/infoSearch.asp
25 Rafie S, Cieri-Hutcherson NE, Frame TR, et al. Pharmacists’ perspectives on prescribing and expanding access to hormonal contraception in pharmacies in the United States. J Pharm Pract 2021; 34(2): 230-8.
| Crossref | Google Scholar | PubMed |
26 Braun V, Victoria C, Elicia B, et al. The online survey as a qualitative research tool. Int J Soc Res Methodol 2021; 24(6): 641-54.
| Crossref | Google Scholar |
27 Pharmacy Council of New Zealand - Te Pou Whakamana Kaimatu o Aotearoa. Pharmacy Workforce Demographics 2022. Wellington, New Zealand; 2022. Available at https://pharmacycouncil.org.nz/wp-content/uploads/2022/10/WorkforceDemographic-Report-2022-Final.pdf
28 Davis SR, Herbert D, Reading M, et al. Health-care providers’ views of menopause and its management: a qualitative study. Climacteric 2021; 24(6): 612-7.
| Crossref | Google Scholar | PubMed |
29 Branvold A, Barner JC. Patient interest in pharmacist-provided menopause and hormone replacement therapy consultations. Int J Pharm Compd 2003; 7(6): 490-4.
| Google Scholar | PubMed |
30 Barner JC, Branvold A. Patients’ willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations. Res Social Adm Pharm 2005; 1(1): 77-100.
| Crossref | Google Scholar | PubMed |
31 Huston SA, Jackowski RM, Kirking DM. Women’s trust in and use of information sources in the treatment of menopausal symptoms. Womens Health Issues 2009; 19(2): 144-53.
| Crossref | Google Scholar | PubMed |
32 DiMaggio JL, Reed-Kane D. Patient satisfaction with pharmacist intervention and consultation in HRT. Int J Pharm Compd 2003; 7(4): 258-63.
| Google Scholar | PubMed |
33 Hu F-S, Reed-Kane D, Draugalis JR, et al. Patient satisfaction with pharmacist intervention and consultation in hormone replacement therapy: an update. Int J Pharm Compd 2006; 10(3): 187.
| Google Scholar | PubMed |
34 Zeolla MM, Cerulli J. Assessment of the effects of a community pharmacy women’s health education program on management of menopause survey scores. J Manag Care Pharm 2004; 10(5): 442-8.
| Crossref | Google Scholar | PubMed |
35 Santen RJ, Mirkin S, Bernick B, et al. Systemic estradiol levels with low-dose vaginal estrogens. Menopause 2020; 27(3): 361-70.
| Crossref | Google Scholar | PubMed |
36 Blouin RA, Adams ML. The role of the pharmacist in health care: expanding and evolving. N C Med J 2017; 78(3): 165-7.
| Crossref | Google Scholar | PubMed |
37 McDonald J, Morris C, Pledger M, et al. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies. BMC Health Serv Res 2021; 21(1): 1147.
| Crossref | Google Scholar | PubMed |
38 Nosek M, Kennedy HP, Gudmundsdottir M. Silence, stigma, and shame: a postmodern analysis of distress during menopause. ANS Adv Nurs Sci 2010; 33(3): 24-36.
| Crossref | Google Scholar | PubMed |
39 Cowell AC, Gilmour A, Atkinson D. Support mechanisms for women during menopause: perspectives from social and professional structures. Women 2024; 4(1): 53-72.
| Crossref | Google Scholar |
40 Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005; 8(Suppl 1): 3-63.
| Crossref | Google Scholar | PubMed |
41 Kim HL, Hollowell CM, Patel RV, et al. Use of new technology in endourology and laparoscopy by American urologists: internet and postal survey. Urology 2000; 56(5): 760-5.
| Crossref | Google Scholar | PubMed |
42 Sammut R, Griscti O, Norman IJ. Strategies to improve response rates to web surveys: a literature review. Int J Nurs Stud 2021; 123: 104058.
| Crossref | Google Scholar | PubMed |
